The Challenges of Developing an API Crystallization Process for a Complex Polymorphic and Highly Solvating System. Part I
Authors:
- 4 November 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 13 (6) , 1327-1337
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Polymorphism2006
- Process Development Challenges to Accommodate A Late-Appearing Stable Polymorph: A Case Study on the Polymorphism and Crystallization of a Fast-Track Drug Development CompoundOrganic Process Research & Development, 2005
- A third blind test of crystal structure predictionActa crystallographica Section B, Structural science, crystal engineering and materials, 2005
- Tricky business: The crystal form of a drug can be the secret to its successScience News, 2004
- Automation of Solid form Screening Procedures in the Pharmaceutical Industry—How to Avoid the BottlenecksCrystallography Reviews, 2004
- High-Throughput Surveys of Crystal Form Diversity of Highly Polymorphic Pharmaceutical CompoundsCrystal Growth & Design, 2003
- Polymorphism - integrated approach from high-throughput screening to crystallization optimizationJournal of Thermal Analysis and Calorimetry, 2003
- THE RIGHT STUFF2003
- Ritonavir: An Extraordinary Example of Conformational PolymorphismPharmaceutical Research, 2001
- Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process DevelopmentOrganic Process Research & Development, 2000